Literature DB >> 27973662

Severe Oral Ulcers Associated With Nivolumab Treatment.

Takeshi Namiki1, Takaaki Hanafusa1, Makiko Ueno1, Keiko Miura2, Hiroo Yokozeki1.   

Abstract

Entities:  

Year:  2017        PMID： 27973662     DOI： 10.1001/jamadermatol.2016.4443

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  4 in total

Review 1.  Checkpoint Inhibitors and the Gut.

Authors:  Tuan Tran; Nguyen Giang Tien Tran; Vincent Ho
Journal:  J Clin Med       Date:  2022-02-04       Impact factor: 4.241

2.  Nivolumab-induced lichenoid granulomatous stomatitis in a patient with advanced melanoma: A case report.

Authors:  P Gouveris; E A Georgakopoulou; A Grigoraki; D N Zouki; V E Kardara; S Ioannou; D Tryfonopoulos; S Demiri; I Gkouveris
Journal:  Mol Clin Oncol       Date:  2022-02-08

Review 3.  Oral Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors: Salivary Gland Dysfunction and Mucosal Diseases.

Authors:  Yoshiaki Yura; Masakazu Hamada
Journal:  Cancers (Basel)       Date:  2022-02-04       Impact factor: 6.639

4.  Chronic and Severe Non-Lichenoid Oral Ulcers Induced by Nivolumab - Diagnostic and Therapeutic Challenge: A Case Report.

Authors:  Andrés F Cardona; Alejandro Ruiz-Patiño; Luisa Ricaurte; Zyanya Lucia Zatarain-Barrón; Feliciano Barrón; Oscar Arrieta
Journal:  Case Rep Oncol       Date:  2020-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.